US BROKER MOVES: META upgraded at Arete; SHW downgraded at UBS
Newsquawk StaffPublished On the live feed at — 3 more headlines followed before this page went public
Newsquawk headlinesUTC
Gilead's (GILD) announces positive results from a Phase 3 study in people with primary biliary cholangitis, showing that treatment with Livdelzi led to significantly more patients achieving normalisation of ALP
Japanese PM Takaichi is reportedly to decide on the plan to lower the consumption tax on food products, by the end of June, Nikkei reports
US BROKER MOVES: META upgraded at Arete; SHW downgraded at UBS
IBM (IBM) has announced plans to invest more than USD 10bln in quantum computing over the next five years
Bristol Myers (BMY) said studies demonstrated iza-bren achieved statistically significant in overall survival and progression-free survival in heavily pretreated, unresectable locally advanced or metastatic triple-negative breast cancer
Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.
Free. No signup, no card.
UPGRADES
- Abivax (ABVX) Upgraded from Underperform to Neutral at Wedbush
- Atlas Energy Solutions (AESI) Upgraded from Market Perform to Outperform at Raymond James; PT USD 25.00
- Eagle Materials (EXP) Upgraded from Underweight to Neutral at JPMorgan; PT USD 225.00
- Guardant Health (GH) Upgraded from In Line to Outperform at Evercore ISI; PT USD 160.00
- Hewlett Packard Enterprise (HPE) Upgraded from Hold to Buy at Loop Capital
- Knight-Swift Transportation (KNX) Upgraded from Neutral to Positive at Susquehanna
- Macerich (MAC) Upgraded from Hold to Buy at Deutsche Bank; PT USD 27.00 (prev. USD 20.00)
- Meta Platforms (META) Upgraded from Neutral to Buy at Arete; PT USD 735.00
- OPTU (OPTU) Upgraded from Underperform to Neutral at BNP Paribas Exane
- Tripadvisor (TRIP) Upgraded from Neutral to Outperform at Wedbush; PT USD 19.00 (prev. USD 12.00)
DOWNGRADES
- Abivax (ABVX) Downgraded from Buy to Hold at Jefferies; PT USD 90.00 (prev. USD 160.00)
- Consolidated Edison (ED) Downgraded from Outperform to Neutral at Mizuho; PT USD 105.00
- Fulcrum Therapeutics (FULC) Downgraded from Overweight to Underweight at Piper Sandler; PT USD 3.00 (prev. USD 23.00)
- Fulcrum Therapeutics (FULC) Downgraded from Outperform to Market Perform at Leerink; PT USD 4.00
- Fulcrum Therapeutics (FULC) Downgraded from Buy to Neutral at H.C. Wainwright; PT USD 3.00 (prev. USD 25.00)
- Fulcrum Therapeutics (FULC) Downgraded from Buy to Hold at Truist Securities; PT USD 4.00 (prev. USD 17.00)
- Fulcrum Therapeutics (FULC) Downgraded from Buy to Hold at Stifel; PT USD 3.00 (prev. USD 25.00)
- Intuit (INTU) Downgraded from Neutral to Sell at Goldman Sachs; PT USD 276.00
- Nu Holdings (NU) Downgraded from Neutral to Underperform at BofA Securities; PT USD 10.00 (prev. USD 16.00)
- Okta (OKTA) Downgraded from Outperform to Neutral at Mizuho; PT USD 125.00 (prev. USD 110.00)
- StandardAero (SARO) Downgraded from Buy to Hold at Jefferies; PT USD 30.00 (prev. USD 34.00)
- Sherwin-Williams (SHW) Downgraded from Buy to Neutral at UBS; PT USD 330.00 (prev. USD 385.00)
- Sociedad Quimica y Minera de Chile (SQM) Downgraded from Overweight to Neutral at JPMorgan; PT USD 100.00 (prev. USD 94.00)
- Taylor Morrison Home (TMHC) Downgraded from Outperform to Sector Perform at RBC Capital; PT USD 72.50
- Taylor Morrison Home (TMHC) Downgraded from Buy to Hold at Truist Securities; PT USD 72.50
INITIATIONS
- Asset Entities (ASST) Initiated with Buy at Benchmark, PT USD 32/shr
- CoreWeave (CRWV) Initiated with Outperform at BNP Paribas Exane, PT USD 192/shr
- Enhabit (ENHA) Initiated with Buy at Canaccord, PT USD 6/shr
- FDXF (FDXF) Initiated with Hold at Truist Securities, PT USD 155/shr
- MANE (MANE) Initiated with Buy at Needham, PT USD 136/shr
- Mirum Pharmaceuticals (MIRM) Initiated with Buy at Citi, PT USD 145/shr
- Martin Marietta Materials (MLM) Initiated with Hold at Berenberg, PT USD 556/shr
- MOBI (MOBI) Initiated with Overweight at JPMorgan, PT USD 15/shr
- MOBI (MOBI) Initiated with Outperform at Wolfe Research, PT USD 19/shr
- MOBI (MOBI) Initiated with Buy at Goldman Sachs, PT USD 31/shr
- MOBI (MOBI) Initiated with Buy at BTIG, PT USD 19/shr
- MOBI (MOBI) Initiated with Buy at BofA Securities, PT USD 16/shr
- Nebius Group (NBIS) Initiated with Neutral at BNP Paribas Exane, PT USD 255/shr
- Neurocrine Biosciences (NBIX) Initiated with Buy at Goldman Sachs, PT USD 213/shr
- Octave Bioscience (OCTV) Initiated with Sector Perform at RBC Capital, PT USD 21/shr
- ODTX (ODTX) Initiated with Overweight at JPMorgan, PT USD 26/shr
- ODTX (ODTX) Initiated with Overweight at Cantor Fitzgerald
- ODTX (ODTX) Initiated with Outperform at Oppenheimer, PT USD 40/shr
- ODTX (ODTX) Initiated with Outperform at Wedbush, PT USD 30/shr
- ODTX (ODTX) Initiated with Buy at TD Cowen
- Take-Two Interactive (TTWO) Initiated with Overweight at Piper Sandler, PT USD 280/shr
- Unity Software (U) Initiated with Overweight at Piper Sandler, PT USD 40/shr
- Vulcan Materials (VMC) Initiated with Hold at Berenberg, PT USD 283/shr
- X4 Pharmaceuticals (XFOR) Initiated with Outperform at Leerink, PT USD 12/shr
Related headlines
- Newsquawk European Market Wrap - 8th September 202614 hours ago
- US EQUITY OPEN: US indices open in the red amid downbeat risk tone after Labor Day holiday15 hours ago
- US Market Wrap: Stocks fall and crude gains amid escalating geopolitics 8 hours ago
- PRE-MARKET AUSTRALIAN, JAPANESE AND SOUTH KOREAN STOCKS NEWS: Samsung Electronics (005930 KS)** - Co. opened an AI chip R&D hub in Yokohama to collaborate with Japanese companies on advanced semiconductor packaging5 hours ago
- US senior Trump administration official says President Trump approved series of proclamations on Canada trade measures, with ban on dairy, most alcohol and motorcycle imports from Canada under Section 338 with restrictions effective in about 3 weeks5 hours ago
- Russia's Kremlin says US President Trump and Russian President Putin spoke on the phone; conversation was open and constructive and lasted one hour.14 hours ago
- [MARKET ANALYSIS] DXY is little changed ahead of inflation data later in the week and despite the US announcing an import ban on some Canadian goods as trade war escalates1 hour ago
- US Secretary of State Rubio says that President Trump has a desire to reach an agreement with Colombia on tariffs6 hours ago
- US President Trump says directing the GSA, working with the USTR, to take all necessary steps to remove Canadian-origin products from GSA’s Multiple Award Schedules unless Canada restores full and fair reciprocity for American farmers and companies8 hours ago
- US President Trump reiterates that Iran will never have a nuclear weapon; says blockade against Iran has been effective14 hours ago
- Google (GOOGL) says Gemini is seeing strong adoption across both large enterprises and small and medium-sized businesses, supporting broader commercial traction for Alphabet's AI platform11 hours ago
- [MARKET ANALYSIS] T-note futures are little changed after yesterday's indecisive mood and with key inflation data due later this week2 hours ago
- CRUDE WRAP: WTI (V6) SETTLES USD 1.55 HIGHER AT USD 93.03/BBL10 hours ago
- [MARKET ANALYSIS] Asia-Pac stocks trade mixed with the region partially shrugging off the weak US lead following a fresh exchange of US-Iran strikes and escalation in the US-Canada trade war1 hour ago
- [MARKET ANALYSIS] Oil prices are underpinned after US and Iran conducted a fresh round of retaliatory strikes2 hours ago
- PBoC sets USD/CNY mid-point at 6.7709 vs Exp. 6.7042 (prev. 6.7804)3 hours ago
- PRE-MARKET TAIWAN AND SINGAPORE STOCKS NEWS: TSMC (2330 TT) plans to adopt ASML’s high-NA EUV lithography equipment for high-volume manufacturing from 20304 hours ago
- OpenAI is launching ChatGPT Images 2.5 on Tuesday, Axios reports10 hours ago
- OpenAI CFO says enterprise business has been "on a tear", CNBC reports11 hours ago
- Merck (MRK) veteran and psychedelics developer tapped for top FDA job8 hours ago
The whole workspace, free to try.
Try it free